Monday 14 May 2018

Connected Enterprise Market size is expected to reach USD 1.94 trillion by 2025 : Grand View Research, Inc.


The global connected enterprise market size is expected to reach USD 1.94 trillion by 2025, according to a new report by Grand View Research, Inc. The increasing need for automation and proliferation of connected devices is providing new growth avenues for the connected enterprise market.
Enterprises are moving toward digital technologies to transform their business operations, improve customer experiences and rapidly respond to emerging threats and opportunities. Industry collaborations with connected technology are gaining prominence for improving agility, productivity, and business process management. Although the Internet-of-Things (IoT) and connected technologies are becoming adept, several organizations have not included their collaboration with smart technologies in business strategies.
The implementation of intelligent networks has improved optimization of assets including equipment reliability, and energy usage and has expanded the capacity of existing assets. Enterprises are integrating people, tools, processes, and platforms comprising infrastructure and applications to disrupt the business productivity with next-generation solutions.
Moreover, organizations are looking for innovative ways to differentiate themselves from their competitors and overcome threats from new entrants. Connected solutions are increasingly adopted for generating new revenue streams and improving profit margins. These solutions help enterprises in increasing their operational efficiency by enabling real-time monitoring of assets. However, fragmented technology standards and growing security concerns are expected to deter the industry growth.
Full research report on connected enterprise market analysis: http://www.grandviewresearch.com/industry-analysis/connected-enterprise-market

Further key findings from the report suggest:
·         Customer experience management is expected to be the fastest-growing segment owing to its transition from being transactional to more interactive and informative solution
·         The managed services segment is expected to grow at a CAGR of over 35% from 2016 to 2025. due to the increasing need for outsourcing IoT-related capabilities
·         The device management platform is anticipated to account for over 25% revenue share by 2025; the need to drive connected products assessment, reduce operational costs, and improve service quality is propelling the demand for a device management platform
·         The healthcare sector is expected to reach a valuation of over USD 150 billion by 2025 on account of its transition from providing provider-centric to patient-centric solutions
·         The Asia Pacific region is expected to be the fastest-growing regional market as the enterprises in the region are deploying connected infrastructure in new areas to improve their revenues.
·         The key industry players include IBM Corporation, Rockwell Automation, Inc., IBM Corporation, Honeywell International, Inc., and PTC Inc.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies
Grand View Research has segmented the connected enterprise market based on component, solution, services, platform, application, and region:
Connected Enterprise Component Outlook (Revenue, USD Billion, 2014 - 2025)
·         Solution
·         Service
·         Platform
Connected Enterprise Solution Outlook (Revenue, USD Billion, 2014 - 2025)
·         Manufacturing execution system
·         Customer experience management
·         Business analytics
·         Application value management
·         Remote monitoring
Connected Enterprise Service Outlook (Revenue, USD Billion, 2014 - 2025)
·         Professional services
·         Managed services
Connected Enterprise Platform Outlook (Revenue, USD Billion, 2014 - 2025)
·         Connectivity management
·         Application enablement and development
·         Device management
Connected Enterprise Application Outlook (Revenue, USD Billion, 2014 - 2025)
·         Manufacturing
·         BFSI
·         IT & telecom
·         Retail
·         Healthcare
·         Food & beverage
·         Others
Connected Enterprise Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


Gamma Oryzanol Market expected to reach USD 2.06 billion by 2022 : Grand View Research, Inc.


The global gamma oryzanol market is expected to reach USD 2.06 billion by 2022, according to a new report by Grand View Research, Inc. Increasing consumer awareness towards a healthy lifestyle is expected to drive product demand over the next seven years.
Improper diet intake coupled with rising health treatment expenditure has urged consumers to switch to alternatives, such as dietary supplements, that offers a balanced diet. Gamma oryzanol plays a significant role in boosting good cholesterol and minimize adverse impacts of unhealthy diet intake.
Rapid urbanization coupled with increasing participation in health clubs and fitness activities are expected to play a vital role in industry growth over the forecast period. High product price along with the lack of consumer awareness are expected to remain major factors hindering market growth.
Technological innovation in the industry includes research initiatives to enhance yield rate from rice bran oil that is anticipated to reduce production costs and enable market players to attain economies of scale. Ongoing technological innovations along with increasing R&D spending is expected to provide significant opportunities for gamma oryzanol manufacturers over the forecast period.
Sports supplement emerged as the principal application segment and accounted for over 40% of total revenue in 2014. The segment is anticipated to witness moderate growth rate owing to high requirement of gamma oryzanol as an essential supplement for sports nutrition.
Full research report on gamma oryzanol market analysis:
http://www.grandviewresearch.com/industry-analysis/gamma-oryzanol-market

Further key findings from the report suggest:
·         The global gamma oryzanol market demand was 11,520.0 tons in 2014 and is expected to reach 18,597.8 tons by 2022, growing at an estimated CAGR of 6.2% from 2015 to 2022
·         Gamma oryzanol demand in cosmetic applications is anticipated to witness the highest growth over the forecast period. The segment is estimated to grow at a CAGR of 6.9% in terms of demand from 2015 to 2022.
·         The product demand in animal feed in the U.S. was over 710 tons in 2014. High requirement of the micronutrient in horses and dogs to enhance muscle development may be attributed to significant development in the segment.
·         Europe was the leading regional market and accounted for 30% of total consumption in 2014. The increasing acceptance of sports supplements as an essential form of nutrition in the UK, Italy, and Germany is expected to remain a key factor driving regional market.
·         Asia Pacific is estimated to witness the highest growth of 7.1%over the forecast period. Abundant raw material availability coupled with significant developments in cosmetics and animal feed sectors particularly in Japan, China, Vietnam, and India are anticipated to steer industry growth.
·         Key players operating in the global gamma oryzanol market include Oryza Oil & Fat Chemical Co., Ltd., Jining Ankang Pharmaceutical, Honson Pharmatech Group, KangCare Bioindustry, Lamotte Oils, Tsuno Rice, Xi’an Realin Biotechnology, Shanghai Freemen LLC, Chromadex Inc., and Sunrise Nutrachem Group Co. Ltd.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/specialty-and-fine-chemicals
Grand View Research has segmented the gamma oryzanol market on the basis of application and region:
Global Gamma Oryzanol Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)
·         Sports supplements
·         Cosmetics
·         Pharmaceuticals
·         Animal feed
Global Gamma Oryzanol Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)
·         North America
o    U.S.
·         Europe
o    France
o    Germany
o    UK
·         Asia Pacific 
o    China
o    India
·         Central & South America
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


Atherectomy Devices Market is expected to reach USD 894.69 million by 2025 : Grand View Research, Inc.


The global atherectomy devices market is expected to reach USD 894.69 million by 2025, based on a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease.
New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown in the region and is looking for potential distributors. This would be the company’s first international market entry and the approval procedure is yet to be completed.
Full research report on atherectomy devices market analysis:  
http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market

Further Key Findings from the Study Suggest:
·         Directional atherectomy devices was the largest segment in terms of revenue in the year 2016. This can be attributed to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
·         Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
·         Geographically, North America held the largest market share in 2015 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
·         Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.
·         Some of the key industry contributors are Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Bayer AG, Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the atherectomy devices market by type and region:
Atherectomy Devices Type Outlook (Market Revenue in USD Million, 2014 - 2025)
·         Directional atherectomy devices
·         Rotational atherectomy devices
·         Orbital atherectomy devices
·         Laser atherectomy devices
Atherectomy Devices Regional Outlook (Market Revenue in USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
·         Middle East and Africa
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com

Industrial Protective Footwear Market size is expected to reach USD 6.56 billion by 2024 : Grand View Research, Inc.


The global industrial protective footwear market size is expected to reach USD 6.56 billion by 2024, according to a new report by Grand View Research, Inc. The substantial growth prospects of the market can be attributed to the rising number of worker accidents across global organizations.
Comfort, innovation, safety, and aesthetic value are the key characteristics of the industrial safety footwear. The global shoe manufacturers over the years have been striving to integrate these features into their products in order to offer improved safety in the workplace as well as provide comfort to workers. Industrial protective shoes have been facing a substantial demand from various industries to avoid fatalities and accidents in the workplace.
With a paradigm shift towards worker safety instead of maximizing profits, a huge demand has been created for protective footwear in hazardous work environments and is anticipated to drive the industry over the forecast period.
In the recent years, safety wear has emerged as an increasingly preferred choice for many companies. These safety products are essential for the prevention and protection against occupational fatalities to workers as well as for the prevention of legal action towards organizations.
However, the high sale volume of spurious and cheap products in the industry is envisioned to challenge the industry growth in the near future. Furthermore, due to the increasing popularity and rising demand for premium branded safety shoes, these products become the sole target for counterfeiting. Thus, high sales volume of counterfeit and low-quality products are expected to challenge the industry growth.
Full research report on industrial protective footwear market analysis: http://www.grandviewresearch.com/industry-analysis/industrial-protective-footwear-market

Further key findings from the report suggest:
·         Leather footwear is presumed to emerge as a predominant product over the forecast period. Leather is increasingly used in safety shoes to provide protection against fatal electric shocks due to its non-conductivity. Moreover, a genuine leather provides protection against falling objects, punctures, cutting hazards, burns, and extreme weather.
·         The rubber safety shoe market was valued at over USD 120 million in 2015 and is expected to grow at a considerable rate over the forecast period. With the emerging use of intense colored rubber materials, safety shoes have now become ergonomically enhanced, water resistant, and lightweight, thereby making them a good choice for various industries.
·         Construction is expected to emerge as a predominant application segment over the next eight years. Growth in this segment is primarily driven by the rising number of workplace accidents, which has, in turn, fueled the adoption of industrial shoes among infrastructure developers to improve occupation safety.
·         Europe led the industry in terms of market share in 2015 and is expected to retain its dominance over the forecast period. The demand in this region is mainly driven by the implementation of standards and compliance with stringent regulations that mandate the use of safety shoes at the workplace. The widespread presence of safety shoe manufacturers in the region is anticipated to drive the industry growth in the region.
·         Low-cost labor, capital, and raw materials, as well as low-interest loans and tax incentives, have forced footwear manufacturers to migrate from North America, UK, and Italy to Asia, especially China. Moreover, the Chinese government is presently attracting footwear manufacturers with various incentives and is working to shift the footwear production sites from the coastal regions to internal territories.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/smart-textiles
Grand View Research has segmented the global industrial protective footwear market on the basis of product, application, and region.
Industrial Protective Footwear Product Outlook (Revenue, USD Million, 2012 - 2024)
·         Leather Footwear
·         Waterproof Footwear
·         Rubber Footwear
·         Plastic Footwear
Industrial Protective Footwear Application Outlook (Revenue, USD Million, 2012 - 2024)
·         Construction
·         Manufacturing
·         Mining
·         Oil and gas
·         Chemicals
·         Food
·         Pharmaceuticals
·         Transportation
Industrial Protective Footwear Regional Outlook (Revenue, USD Million, 2012 - 2024)
·         North America
·         Europe
·         Asia Pacific
·         RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com